3D Printing Financials: Materialise Stays Profitable in Q2 Thanks to Medical Division
Materialise maintained profitability in Q2 of 2025, driven by its strong medical segment and cost controls, despite challenges in other areas. Revenue decreased by 5.8%, but the company still achieved a net profit of €200,000. The medical division excelled with innovative collaborations and FDA clearance for personalized knee surgery planning. Materialise restructured its manufacturing division, focusing on metal series production, and announced plans to engage with the defense sector. Despite currency fluctuations, the company remains confident in its long-term strategy and aims to enhance operational profitability through cost efficiencies.